Medicine
Mektovi 15 mg tablet
Mektovi 15 mg tablet is a prescription medicine containing Binimetinib for oral use, marketed by Array BioPharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and…
Key facts
- Active ingredient (INN)
- Binimetinib
- Brand
- Mektovi
- Strength
- 15 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 bottle, 90 tablets
- Marketing authorisation holder
- Array BioPharma
- Manufacturer
- Array BioPharma
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01EE03 Binimetinib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 June 2018
- Identifiers
- RxCUI 2049127, 2049133DailyMed set ID 6c3408ac-d401-4925-8a03-26591afbc240NDC 70255-010Application NDA210498
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 180 tablet, film coated in 1 bottle | 70255-010-02 | Array BioPharma | 27 June 2018 |
| 90 tablet, film coated in 1 bottle | 70255-010-03 | Array BioPharma | 27 June 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Binimetinib is a prescription medicine indicated in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test, among other approved uses. MedsAcross supplies Binimetinib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BinimetinibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MEKTOVI prescribing information (Array BioPharma) · U.S. National Library of Medicine, DailyMed
- Mektovi: European public assessment report (EPAR) · European Medicines Agency
Need Mektovi 15 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.